SCHEMBL7017443

SCHEMBL7017443

O=S(=O)(CCCNc1ccccc1)c1ccc2cc(Cl)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.45
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
ALDH1A1 P00352 4/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
GSR P00390 3/20 0.40
F2 P00734 2/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
SNCA P37840 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
CYP19A1 P11511 1/20 0.39
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011601 0.80 F10 (0.56) F10ALDH1A1HTTGAAKDM4E
SCHEMBL7008974 0.78 F10 (0.47) F10ALDH1A1KDM4EHPGD
SCHEMBL7014747 0.77 F10 (0.46) F10ALDH1A1KDM4EHPGD
SCHEMBL7018080 0.77 F10 (0.45) F10
Trifluoroacetic Acid SCHEMBL7014625 0.77 F10 (0.46) F10ALDH1A1KDM4EHPGD
SCHEMBL7017324 0.76 F10 (0.53) F10ALDH1A1HTTGAAKDM4E
SCHEMBL7015078 0.76 F10 (0.44) F10ALDH1A1HTT
SCHEMBL7015561 0.76 CA2 (0.51) F10ALDH1A1HTT
SCHEMBL7010156 0.75 PPARG (0.52) F10ALDH1A1HTTPPARG
Hydrochloric Acid SCHEMBL7012167 0.75 F10 (0.43) F10ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH F10 717/4885PSEN1 4632/4885PSEN2 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.